Our results show that the expression of NAT2 is strongly related to that of VDR in CRC clinical samples, and 1,25(OH)2D3 induces the expression of NAT2 by transcriptional regulation of VDR. The gene discussed is NAT2; the disease is colorectal carcinoma.